Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 9, Issue 12

2021 December - 137 articles

Cover Story: The scarcity of alternative therapeutics against viral infections as efficient as vaccines makes them essential in such areas as animal care. Whole-pathogen inactivated vaccines present substantial biosafety and handling advantages and thus a higher market acceptance in the animal production industry, including in aquaculture. Viral nervous necrosis (VNN) caused by the nervous necrosis virus (NNV) affects a broad range of primarily marine fish species, with mass mortality rates among larvae and juveniles. Its genetic diversification may hinder the effective implementation of vaccines. The present study describes different rapid inactivation procedures for developing an inactivated vaccine against a new NNV isolate confirmed to possess deadly effects upon the European seabass (Dicentrarchus labrax), an important farmed fish species. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (137)

  • Review
  • Open Access
26 Citations
12,420 Views
15 Pages

20 December 2021

mRNA COVID-19 vaccines have hegemonized the world market, and their administration to the population promises to stop the pandemic. However, the waning of the humoral immune response, which does not seem to last so many months after the completion of...

  • Review
  • Open Access
34 Citations
9,544 Views
12 Pages

20 December 2021

The insect cell expression system has previously been proposed as the preferred biosecurity strategy for production of any vaccine, particularly for future influenza pandemic vaccines. The development and regulatory risk for new vaccine candidates is...

  • Article
  • Open Access
17 Citations
5,003 Views
17 Pages

Who Got Vaccinated for COVID-19? Evidence from Japan

  • Toshihiro Okubo,
  • Atsushi Inoue and
  • Kozue Sekijima

20 December 2021

Vaccination has been critical to reducing infections and deaths during the coronavirus disease 2019 (COVID-19) pandemic. While previous studies have investigated attitudes toward taking a vaccine, studies on the determinants of COVID-19 vaccination b...

  • Feature Paper
  • Article
  • Open Access
9 Citations
4,656 Views
16 Pages

Mycoplasma suis Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals

  • Shujiang Xue,
  • Kangseok Seo,
  • Miaosen Yang,
  • Chengdu Cui,
  • Meng Yang,
  • Siyu Xiang,
  • Zongbin Yan,
  • Shengjun Wu,
  • Jincheng Han and
  • Xin Jin
  • + 2 authors

20 December 2021

Recombinant protein technology has emerged as an excellent option for vaccine development. However, prior to our study, the immune induction ability of recombinant Mycoplasma suis alpha-enolase (rMseno) in animals remained unclear. The purpose of thi...

  • Review
  • Open Access
16 Citations
7,255 Views
16 Pages

Promising Expectations for Pneumococcal Vaccination during COVID-19

  • Hyobin Im,
  • Jinhui Ser,
  • Uk Sim and
  • Hoonsung Cho

20 December 2021

The emergence of new viral infections has increased over the decades. The novel virus is one such pathogen liable for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, popularly known as coronavirus disease 2019 (COVID-19). Most...

  • Article
  • Open Access
18 Citations
4,041 Views
11 Pages

20 December 2021

At the end of 2020, COVID-19 vaccination programs were initiated in many countries, including Poland. The first vaccine approved in Poland was the BNT162b2 mRNA preparation (Pfizer/BioNTech), and the first vaccinated group were healthcare workers. Th...

  • Article
  • Open Access
5 Citations
2,968 Views
8 Pages

20 December 2021

We observe that a residue R of the spike glycoprotein of SARS-CoV-2 that has mutated in one or more of the current variants of concern or interest, or under monitoring, rarely participates in a backbone hydrogen bond if R lies in the S1 subunit and u...

  • Article
  • Open Access
3 Citations
3,505 Views
18 Pages

20 December 2021

Collagen is the main component of the extracellular matrix (ECM) and might play an important role in tumor microenvironments. However, the relationship between collagen and clear cell renal cell cancer (ccRCC) is still not fully clarified. Hence, we...

  • Case Report
  • Open Access
19 Citations
8,054 Views
11 Pages

Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination

  • Caterina Francesca Bagella,
  • Davide G. Corda,
  • Pietro Zara,
  • Antonio Emanuele Elia,
  • Elisa Ruiu,
  • Elia Sechi and
  • Paolo Solla

19 December 2021

Recently several patients, who developed Guillain–Barré syndrome characterized by prominent bifacial weakness after ChAdOx1 nCoV-19 vaccination, were described from different centers. We recently observed a patient who developed a simila...

  • Review
  • Open Access
78 Citations
12,870 Views
25 Pages

Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy

  • Kajal H. Gupta,
  • Christina Nowicki,
  • Eileena F. Giurini,
  • Amanda L. Marzo and
  • Andrew Zloza

18 December 2021

Currently approximately 10 million people die each year due to cancer, and cancer is the cause of every sixth death worldwide. Tremendous efforts and progress have been made towards finding a cure for cancer. However, numerous challenges have been fa...

  • Article
  • Open Access
47 Citations
8,285 Views
14 Pages

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection

  • Mariapia Guerrieri,
  • Beatrice Francavilla,
  • Denise Fiorelli,
  • Marzia Nuccetelli,
  • Francesco Maria Passali,
  • Luca Coppeta,
  • Giuseppina Somma,
  • Sergio Bernardini,
  • Andrea Magrini and
  • Stefano Di Girolamo

18 December 2021

SARS-CoV-2 antibody assays are crucial in managing the COVID-19 pandemic. Approved mRNA COVID-19 vaccines are well known to induce a serum antibody responses against the spike protein and its RBD. Mucosal immunity plays a major role in the fight agai...

  • Article
  • Open Access
46 Citations
6,797 Views
14 Pages

18 December 2021

As the ongoing COVID-19 pandemic poses a global threat, it is of utmost importance that governments should find effective means of combating vaccine hesitancy and encouraging their citizens to vaccinate. In our article, we compare the vaccination out...

  • Article
  • Open Access
27 Citations
4,445 Views
11 Pages

Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months

  • Yushi Nomura,
  • Michiru Sawahata,
  • Yosikazu Nakamura,
  • Ryousuke Koike,
  • Otohiro Katsube,
  • Koichi Hagiwara,
  • Seiji Niho,
  • Norihiro Masuda,
  • Takaaki Tanaka and
  • Kumiya Sugiyama

18 December 2021

Objective: We aimed to determine antibody titers at six months and their percentage change from three to six months after the second dose of the BNT162b2 coronavirus disease 2019 (COVID-19) mRNA vaccine (Pfizer/BioNTech) and to explore clinical varia...

  • Article
  • Open Access
4 Citations
3,346 Views
14 Pages

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses

  • Sarah Brendle,
  • Nancy Cladel,
  • Karla Balogh,
  • Samina Alam,
  • Neil Christensen,
  • Craig Meyers and
  • Jiafen Hu

18 December 2021

Human papillomavirus (HPV) 16 capsids have been chosen as a DNA delivery vehicle in many studies. Our preliminary studies suggest that HPV58 capsids could be better vehicles than HPV16 capsids to deliver encapsidated DNA in vitro and in vivo. In the...

  • Article
  • Open Access
4 Citations
3,623 Views
12 Pages

17 December 2021

In this study, we explore the recent setup of a digital vaccination record in Austria. Working from a social-scientific perspective, we find that the introduction of the electronic vaccination pass was substantially accelerated by the COVID-19 pandem...

  • Article
  • Open Access
4 Citations
4,422 Views
13 Pages

COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia

  • Eva S. L. Pedersen,
  • Maria Christina Mallet,
  • Yin Ting Lam,
  • Sara Bellu,
  • Isabelle Cizeau,
  • Fiona Copeland,
  • Trini Lopez Fernandez,
  • Michele Manion,
  • Amanda L. Harris and
  • COVID-PCD Patient Advisory Group
  • + 4 authors

17 December 2021

Primary ciliary dyskinesia (PCD) is a rare genetic disease that causes recurrent respiratory infections. People with PCD may be at higher risk of severe coronavirus disease 2019 (COVID-19), and therefore vaccination against severe acute respiratory s...

  • Article
  • Open Access
10 Citations
3,045 Views
10 Pages

Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population

  • Rosa Papadopoli,
  • Caterina De Sarro,
  • Caterina Palleria,
  • Luca Gallelli,
  • Claudia Pileggi and
  • Giovambattista De Sarro

17 December 2021

Background: This study aims to investigate the extent of the BNT162b2 mRNA vaccine-induced antibodies against SARS-CoV-2 in a large cohort of Italian subjects belonging to the early vaccinated cohort in Italy. Methods: A prospective study was conduct...

  • Case Report
  • Open Access
8 Citations
3,526 Views
6 Pages

16 December 2021

We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration. The thrombocytopenia condition improved after administering steroid tre...

  • Article
  • Open Access
12 Citations
5,263 Views
25 Pages

Effects of Pope Francis’ Religious Authority and Media Coverage on Twitter User’s Attitudes toward COVID-19 Vaccination

  • Arkadiusz Gaweł,
  • Marzena Mańdziuk,
  • Marek Żmudziński,
  • Małgorzata Gosek,
  • Marlena Krawczyk-Suszek,
  • Mariusz Pisarski,
  • Andrzej Adamski and
  • Weronika Cyganik

16 December 2021

This paper is interdisciplinary and combines the research perspective of medical studies with that of media and social communication studies and theological studies. The main goal of this article is to determine [from arguments on all sides of the is...

  • Feature Paper
  • Review
  • Open Access
24 Citations
6,170 Views
13 Pages

Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis

  • Maria Teresa Palano,
  • Matteo Gallazzi,
  • Martina Cucchiara,
  • Andrea De Lerma Barbaro,
  • Daniela Gallo,
  • Barbara Bassani,
  • Antonino Bruno and
  • Lorenzo Mortara

16 December 2021

The tumor immune microenvironment (TIME) has largely been reported to cooperate on tumor onset and progression, as a consequence of the phenotype/functional plasticity and adaptation capabilities of tumor-infiltrating and tumor-associated immune cell...

  • Systematic Review
  • Open Access
21 Citations
4,946 Views
21 Pages

Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021

  • Chang-Jie Cheng,
  • Chun-Yi Lu,
  • Ya-Hui Chang,
  • Yu Sun,
  • Hai-Jui Chu,
  • Chun-Yu Lee,
  • Chang-Hsiu Liu,
  • Cheng-Huai Lin,
  • Chien-Jung Lu and
  • Chung-Yi Li

16 December 2021

Large clinical trials have proven the efficacy of the COVID-19 vaccine, and the number of studies about the effectiveness rapidly grew in the first half of the year after mass vaccination was administrated globally. This rapid review aims to provide...

  • Review
  • Open Access
169 Citations
25,955 Views
31 Pages

16 December 2021

Vaccination is a key component of public health policy with demonstrated cost-effective benefits in protecting both human and animal populations. Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuat...

  • Communication
  • Open Access
11 Citations
4,061 Views
16 Pages

16 December 2021

Crimean–Congo hemorrhagic fever virus (CCHFV) infrequently causes hemorrhagic fever in humans with a case fatality rate of 30%. Currently, there is neither an internationally approved antiviral drug nor a vaccine against the virus. A replicon b...

  • Article
  • Open Access
7 Citations
5,383 Views
25 Pages

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

  • Nadia Oreshkova,
  • Sebenzile K. Myeni,
  • Niraj Mishra,
  • Irina C. Albulescu,
  • Tim J. Dalebout,
  • Eric J. Snijder,
  • Peter J. Bredenbeek,
  • Kai Dallmeier and
  • Marjolein Kikkert

16 December 2021

The tremendous global impact of the current SARS-CoV-2 pandemic, as well as other current and recent outbreaks of (re)emerging viruses, emphasize the need for fast-track development of effective vaccines. Yellow fever virus 17D (YF17D) is a live-atte...

  • Protocol
  • Open Access
9 Citations
5,890 Views
21 Pages

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay

  • Ahmed O. Shalash,
  • Armira Azuar,
  • Harrison Y. R. Madge,
  • Naphak Modhiran,
  • Alberto A. Amarilla,
  • Benjamin Liang,
  • Alexander A. Khromykh,
  • Daniel Watterson,
  • Paul R. Young and
  • Mariusz Skwarczynski
  • + 1 author

16 December 2021

This protocol describes an ELISA-based procedure for accurate measurement of SARS-CoV-2 spike protein-receptor binding domain (RBD) neutralization efficacy by murine immune serum. The procedure requires a small amount of S-protein/RBD and angiotensin...

  • Review
  • Open Access
7 Citations
5,062 Views
10 Pages

Optimising COVID-19 Vaccination Policy to Mitigate SARS-CoV-2 Transmission within Schools in Zimbabwe

  • Grant Murewanhema,
  • Solomon Mukwenha,
  • Tafadzwa Dzinamarira,
  • Zindoga Mukandavire,
  • Diego Cuadros,
  • Roda Madziva,
  • Innocent Chingombe,
  • Munyaradzi Mapingure,
  • Helena Herrera and
  • Godfrey Musuka

15 December 2021

The COVID-19 pandemic has disrupted the learning of millions of children across the world. Since March 2020 when the first cases of COVID-19 were reported in Zimbabwe, the country, like many others, has gone through periods of closing and re-opening...

  • Review
  • Open Access
45 Citations
10,009 Views
18 Pages

Oral Cholera Vaccine Efficacy and Effectiveness

  • Katerina Rok Song,
  • Jacqueline Kyungah Lim,
  • Se Eun Park,
  • Tarun Saluja,
  • Sung-Il Cho,
  • Tram Anh Wartel and
  • Julia Lynch

15 December 2021

Although measuring vaccine efficacy through the conventional phase III study design, randomized, double-blinded controlled trial serves as the “gold standard”, effectiveness studies, conducted in the context of a public health program, se...

  • Article
  • Open Access
16 Citations
5,303 Views
17 Pages

15 December 2021

Newcastle disease virus (NDV) and infectious bursal disease virus (IBDV) are the two most important and widespread viruses causing huge economic losses in the global poultry industry. Outbreaks of genotype VII NDV and IBDV variants in vaccinated poul...

  • Review
  • Open Access
4 Citations
5,802 Views
9 Pages

15 December 2021

HBV vaccination effectively prevents HBV transmission and the development of liver cancer. Disease progression and liver-related complications are more common in HIV-1/HBV co-infected than HBV mono-infected individuals. A considerable body of literat...

  • Article
  • Open Access
6 Citations
4,733 Views
14 Pages

Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy

  • Maria Francesca Piazza,
  • Daniela Amicizia,
  • Chiara Paganino,
  • Francesca Marchini,
  • Matteo Astengo,
  • Federico Grammatico,
  • Cecilia Trucchi,
  • Paolo Romairone,
  • Simona Simonetti and
  • Filippo Ansaldi
  • + 1 author

15 December 2021

According to WHO estimates, varicella disease is responsible of a worldwide significant burden in terms of hospitalizations, complications, and deaths, with more than 90% of cases under 12 years old. This study aims at evaluating the clinical, epidem...

  • Review
  • Open Access
66 Citations
7,701 Views
25 Pages

Parents’ Decisions to Vaccinate Children against COVID-19: A Scoping Review

  • Fengming Pan,
  • Hongyu Zhao,
  • Stephen Nicholas,
  • Elizabeth Maitland,
  • Rugang Liu and
  • Qingzhen Hou

14 December 2021

Since 2019, the COVID-19 pandemic has resulted in sickness, hospitalizations, and deaths of the old and young and impacted global social and economy activities. Vaccination is one of the most important and efficient ways to protect against the COVID-...

  • Article
  • Open Access
16 Citations
3,653 Views
11 Pages

Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection

  • Hannah G. Juncker,
  • Sien J. Mulleners,
  • Marit J. van Gils,
  • Tom P. L. Bijl,
  • Christianne J. M. de Groot,
  • Dasja Pajkrt,
  • Aniko Korosi,
  • Johannes B. van Goudoever and
  • Britt J. van Keulen

14 December 2021

SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated lactating women and might provide protection to the breastfed infant against COVID-19. Differences in antibody response after these types of exposure are unknown. I...

  • Review
  • Open Access
38 Citations
5,119 Views
12 Pages

COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy

  • Sansone Pasquale,
  • Giaccari Luca Gregorio,
  • Aurilio Caterina,
  • Coppolino Francesco,
  • Passavanti Maria Beatrice,
  • Pota Vincenzo and
  • Pace Maria Caterina

14 December 2021

The management of the COVID-19 pandemic represents a challenging process, especially for low- and middle-income countries (LMICs) due to the serious economic and health resource problems it generates. In this article, we assess COVID-19 situation in...

  • Article
  • Open Access
9 Citations
4,369 Views
11 Pages

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

  • Davide Firinu,
  • Andrea Perra,
  • Marcello Campagna,
  • Roberto Littera,
  • Federico Meloni,
  • Francesca Sedda,
  • Maria Conti,
  • Giulia Costanzo,
  • Monica Erbi and
  • Luchino Chessa
  • + 7 authors

14 December 2021

In several countries, thrombotic events after vaccination with ChAdOx1 nCoV-19 have led to heterologous messenger RNA (mRNA) boosting. We tested the antibody response to SARS-CoV-2 spike protein four weeks after heterologous priming with the ChAdOx1...

  • Article
  • Open Access
12 Citations
3,458 Views
12 Pages

Construction of Recombinant Lactococcus lactis Strain Expressing VP1 Fusion Protein of Duck Hepatitis A Virus Type 1 and Evaluation of Its Immune Effect

  • Xiaoting Zhang,
  • Ruihua Zhang,
  • Jingyu Wang,
  • Nana Sui,
  • Guige Xu,
  • Hui Yan,
  • Yanli Zhu,
  • Zhijing Xie and
  • Shijin Jiang

14 December 2021

With the continuous development of duck farming and the increasing breeding density, the incidence of duck hepatitis A virus type 1 (DHAV-1) has been on the rise, seriously endangering the development of duck farming. To reduce the use of antibiotics...

  • Article
  • Open Access
1 Citations
3,721 Views
17 Pages

14 December 2021

In this study, we investigated the mechanism of transcutaneous adjuvant activity of the CpG-oligonucleotide (K3) in mice. Transcutaneous immunization (TCI) with an ovalbumin-loaded self-dissolving microneedle patch (OVA-sdMN) and K3-loaded hydrophili...

  • Article
  • Open Access
20 Citations
4,431 Views
11 Pages

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies

  • Mohammad Shehab,
  • Fatema Alrashed,
  • Ahmad Alfadhli,
  • Khazna Alotaibi,
  • Abdullah Alsahli,
  • Hussain Mohammad,
  • Preethi Cherian,
  • Irina Al-Khairi,
  • Thangavel Alphonse Thanaraj and
  • Fahd Al-Mulla
  • + 4 authors

13 December 2021

Introduction: The immunogenicity of SARS-CoV-2 vaccines in patients with inflammatory bowel disease (IBD) on biologic therapies is not well studied. The goal of this study was to measure the serological response to BNT162b2 and ChAdOx1 nCoV-19 vaccin...

  • Article
  • Open Access
10 Citations
3,028 Views
17 Pages

Characterization of a Novel Cysteine Protease Inhibitor from Poultry Red Mites: Potential Vaccine for Chickens

  • Sotaro Fujisawa,
  • Shiro Murata,
  • Masayoshi Isezaki,
  • Takuma Ariizumi,
  • Takumi Sato,
  • Eiji Oishi,
  • Akira Taneno,
  • Naoya Maekawa,
  • Tomohiro Okagawa and
  • Kazuhiko Ohashi
  • + 2 authors

13 December 2021

Poultry red mite (PRM; Dermanyssus gallinae) is a hazardous, blood-sucking ectoparasite of birds that constitutes a threat to poultry farming worldwide. Acaricides, commonly used in poultry farms to prevent PRMs, are not effective because of the rapi...

  • Article
  • Open Access
8 Citations
3,918 Views
15 Pages

Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle

  • Hyunji Choi,
  • Sun-Min Lee,
  • Seungjin Lim,
  • Kyung-Hwa Shin,
  • Taeyun Kim,
  • Won-joo Kim,
  • Misook Yun and
  • Seung-Hwan Oh

13 December 2021

The immune-acquired responses after vaccination vary depending on the type of vaccine and the individual. The purpose of this study was to investigate the relationship between the acquisition of immunity and the side effects, health status, and lifes...

  • Review
  • Open Access
5 Citations
5,552 Views
13 Pages

COVID-19 Vaccination: The Mainspring of Challenges and the Seed of Remonstrance

  • Hoda Najjar,
  • Hadeel T. Al-Jighefee,
  • Abeer Qush,
  • Muna Nizar Ahmed,
  • Sara Awwad and
  • Layla Kamareddine

13 December 2021

As of March 2020, the time when the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic, our existence has been threatened and the lives of millions have been claimed. With...

  • Article
  • Open Access
6 Citations
4,214 Views
11 Pages

Equity in Vaccine Trials for Higher Weight People? A Rapid Review of Weight-Related Inclusion and Exclusion Criteria for COVID-19 Clinical Trials

  • Jessica Campbell,
  • Juliet Sutherland,
  • Danielle Bucknall,
  • Lily O’Hara,
  • Anita Heywood,
  • Matthew Hobbs,
  • Angela Ballantyne and
  • Lesley Gray

11 December 2021

Higher weight status, defined as body mass index (BMI) ≥ 30 kg/m2, is frequently described as a risk factor for severity and susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (known as COVID-19). Therefore, stu...

  • Article
  • Open Access
21 Citations
6,294 Views
14 Pages

11 December 2021

The COVID-19 vaccine rollout is crucial to lifting community and economic restrictions. This cross-sectional study aimed to assess: (a) COVID-19 vaccine uptake and associated factors; (b) COVID-19 vaccine intentions and associated factors; (c) commun...

  • Article
  • Open Access
5 Citations
4,156 Views
15 Pages

11 December 2021

Modern cell culture-based technology eliminates vaccine manufactures reliance on embryonated chicken eggs, which may become compromised during an avian influenza pandemic. Four studies (total N = 6230) assessed the immunogenicity and safety of mammal...

  • Article
  • Open Access
23 Citations
3,373 Views
13 Pages

Intention of Parents to Immunize Children against SARS-CoV-2 in Italy

  • Luisa Russo,
  • Ileana Croci,
  • Ilaria Campagna,
  • Elisabetta Pandolfi,
  • Alberto Villani,
  • Antonino Reale,
  • Maria Antonietta Barbieri,
  • Massimiliano Raponi,
  • Francesco Gesualdo and
  • Alberto Eugenio Tozzi

11 December 2021

Several countries have targeted adolescents for immunization against SARS-CoV-2 to mitigate COVID-19 spread. In Italy, immunization for children ≥ 12 years has been available starting from June 2021. We conducted a cross-sectional study to investi...

  • Article
  • Open Access
38 Citations
6,156 Views
8 Pages

Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis

  • Lutz Achtnichts,
  • Barbara Jakopp,
  • Michael Oberle,
  • Krassen Nedeltchev,
  • Christoph Andreas Fux,
  • Johann Sellner and
  • Oliver Findling

11 December 2021

CD20 depletion is a risk factor for unfavorable outcomes of COVID-19 in people with MS (pwMS). Evidence suggests that protective IgG response to mRNA-based vaccines in B cell-depleted individuals is limited. We studied the seroconversion after the th...

  • Article
  • Open Access
8 Citations
5,189 Views
19 Pages

Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK

  • Dauda Ibrahim,
  • Zoltán Kis,
  • Kyungjae Tak,
  • Maria M. Papathanasiou,
  • Cleo Kontoravdi,
  • Benoît Chachuat and
  • Nilay Shah

10 December 2021

Vaccination plays a key role in reducing morbidity and mortality caused by infectious diseases, including the recent COVID-19 pandemic. However, a comprehensive approach that allows the planning of vaccination campaigns and the estimation of the reso...

  • Article
  • Open Access
6 Citations
4,133 Views
19 Pages

Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures

  • Simon Pageaud,
  • Catherine Pothier,
  • Christophe Rigotti,
  • Anne Eyraud-Loisel,
  • Jean-Pierre Bertoglio,
  • Alexis Bienvenüe,
  • Nicolas Leboisne,
  • Nicolas Ponthus,
  • Romain Gauchon and
  • on behalf of the Group CovDyn (Covid Dynamics)
  • + 5 authors

10 December 2021

The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epid...

  • Article
  • Open Access
77 Citations
7,993 Views
17 Pages

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study

  • Xiaozhen Lai,
  • He Zhu,
  • Jiahao Wang,
  • Yingzhe Huang,
  • Rize Jing,
  • Yun Lyu,
  • Haijun Zhang,
  • Huangyufei Feng,
  • Jia Guo and
  • Hai Fang

10 December 2021

Coronavirus disease 2019 (COVID-19) booster vaccination has been proposed in response to the new challenges of highly contagious variants, yet few studies have examined public acceptance of boosters. This study examined public acceptance of COVID-19...

  • Article
  • Open Access
16 Citations
5,223 Views
9 Pages

Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection

  • Oleguer Parés-Badell,
  • Xavier Martínez-Gómez,
  • Laia Pinós,
  • Blanca Borras-Bermejo,
  • Sonia Uriona,
  • Susana Otero-Romero,
  • José Ángel Rodrigo-Pendás,
  • Yolima Cossio-Gil,
  • Antònia Agustí and
  • Magda Campins
  • + 1 author

10 December 2021

The aim of this study was to assess adverse reactions to COVID-19 vaccines, comparing the BNT162b2 or the mRNA-1273 COVID-19 vaccines and the presence and seriousness of a previous COVID-19 infection. We conducted a cross-sectional online survey of v...

  • Review
  • Open Access
10 Citations
4,296 Views
21 Pages

10 December 2021

Avian influenza viruses from the A/H5 A/goose/Guangdong/1/1996 (GsGd) lineage pose a continuing threat to animal and human health. Since their emergence in 1997, these viruses have spread across multiple continents and have become enzootic in poultry...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X